Acasă › Cancer pulmonar cu celule non-pătrate › Illinois › Arlington Heights
Studii clinice pentru Cancer pulmonar cu celule non-pătrate în Arlington Heights, IL
12 studii pentru Cancer pulmonar cu celule non-pătrate caută participanți în și în jurul orașului Arlington Heights (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
În curs de recrutareFaza 3
- Advocate Good Shepherd Hospital, Barrington · La 9 mi distanță
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
În curs de recrutareFaza 3
- Illinois Cancer Specialists, Arlington Heights
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
În curs de recrutareFaza 3
- Illinois Cancer Specialists, Arlington Heights
Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer
În curs de recrutareStudiu observațional
- Northwest Oncology & Hematology, Elk Grove Village · La 6 mi distanță
An External Control Arm Study in Non-Small Cell Lung Cancer
În curs de recrutareStudiu observațional
- Northwest Oncology and Hematology, Rolling Meadows · La 2 mi distanță
- Northwest Oncology and Hematology, Elk Grove · La 6 mi distanță
- Northwest Oncology and Hematology, Hoffman Estates · La 6 mi distanță
- și încă 1
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
În curs de recrutareFaza 2/3
- Local Institution - 007-883-A, Arlington Heights
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
În curs de recrutareFaza 3
- Illinois Cancer Specialists, Arlington Heights
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
În curs de recrutareFaza 3
- Northwest Oncology & Hematology, Barrington · La 9 mi distanță
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
În curs de recrutareFaza 2
- Advocate Good Shepherd Hospital, Barrington · La 9 mi distanță
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
În curs de recrutareFaza 2
- Advocate Good Shepherd Hospital, Barrington · La 9 mi distanță
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
În curs de recrutareFaza 2/3
- Advocate Good Shepherd Hospital, Barrington · La 9 mi distanță
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
În curs de recrutareStudiu observațional
- Advocate Good Shepherd Hospital, Barrington · La 9 mi distanță
Studii pentru Cancer pulmonar cu celule non-pătrate în alte orașe
- Houston, TX145 studii
- New York City, NY121 studii
- Arlington, VA104 studii
- Nashville, TN97 studii
- Boston, MA90 studii
- Los Angeles, CA87 studii
- St. Louis, MO73 studii
- Chicago, IL61 studii
- Baltimore, MD60 studii
- San Antonio, TX59 studii
- Columbus, OH57 studii
- Washington, DC55 studii
Alte studii în Arlington Heights
- Cancer colorectal12 studii
- Cancer pulmonar9 studii
- Cancer de sân7 studii
- Insuficiență cardiacă7 studii
- Cancer metastatic6 studii
- Colită ulcerativă6 studii
- Cancer de colon6 studii
- Cancer ovarian5 studii
- Obezitate5 studii
- Supraponderalitate5 studii
- Cancer de prostată3 studii
- Afecțiuni ale pielii3 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.